NDC 81033-427-05 - Lacosamide Oral Solution
This NDC is not currently matched to an FDA NDC product listing in FDA.report, but it is a valid NDC-form code. FDA.report is showing the available DailyMed label context for the product root.
- Product NDC
- 81033-427
- Requested NDC
- 81033-427-05
- Package NDCs from labels
- 81033-427-05, 81033-427-14, 81033-427-10, 81033-427-16, 81033-427-15, 81033-427-17, 81033-427-20, 81033-427-18
- Manufacturer
- Kesin Pharmaceutical Corporation
- Effective date
- 2025-08-05
- Current FDA listing
- Not matched in FDA.report NDC product tables
DailyMed Labels#
| Label | Manufacturer | Effective date | Type |
|---|---|---|---|
| Lacosamide Oral Solution - Kesin Pharmaceutical Corporation | Kesin Pharmaceutical Corporation | 2025-08-05 | HUMAN PRESCRIPTION DRUG LABEL |
DailyMed Package Descriptions#
| Package NDC | Product | Description | Form | Quantity | Strength | SPL version |
|---|---|---|---|---|---|---|
| 81033-427-05 | Lacosamide Oral Solution | 5 mL in 1 CUP, UNIT-DOSE | SOLUTION | 5 | 1 | |
| 81033-427-10 | Lacosamide Oral Solution | 10 mL in 1 CUP, UNIT-DOSE | SOLUTION | 10 | 1 | |
| 81033-427-14 | Lacosamide Oral Solution | 10 in 1 CARTON | SOLUTION | 10 | 1 | |
| 81033-427-15 | Lacosamide Oral Solution | 15 mL in 1 CUP, UNIT-DOSE | SOLUTION | 15 | 1 | |
| 81033-427-16 | Lacosamide Oral Solution | 10 in 1 CARTON | SOLUTION | 10 | 1 | |
| 81033-427-17 | Lacosamide Oral Solution | 10 in 1 CARTON | SOLUTION | 10 | 1 | |
| 81033-427-18 | Lacosamide Oral Solution | 10 in 1 CARTON | SOLUTION | 10 | 1 | |
| 81033-427-20 | Lacosamide Oral Solution | 20 mL in 1 CUP, UNIT-DOSE | SOLUTION | 20 | 1 |
DailyMed Billing Units#
| Package NDC | Billing unit | Product NDC | DailyMed indexing SPL | SPL version | Effective |
|---|---|---|---|---|---|
| 81033-427-05 | ML - Milliliter | 81033-427 | 2d3d530a-15f2-4d4d-9e5d-f710122063ab | 1 | 2025-12-16 |
| 81033-427-10 | ML - Milliliter | 81033-427 | e7759c3a-f29e-436d-a32b-d8bc43919794 | 1 | 2025-12-16 |
| 81033-427-14 | ML - Milliliter | 81033-427 | 89afc664-5f8c-4f57-b098-6b73f9d090e0 | 1 | 2025-12-16 |
| 81033-427-15 | ML - Milliliter | 81033-427 | eb72a5ff-67c1-477c-aeda-b046b4c26a2a | 1 | 2026-03-17 |
| 81033-427-16 | ML - Milliliter | 81033-427 | b7dd91a8-307a-419e-ba67-9d10de53a4fc | 1 | 2025-12-16 |
| 81033-427-17 | ML - Milliliter | 81033-427 | 5f9c12cb-f676-4679-9ec8-57f0c582724e | 1 | 2026-03-17 |
| 81033-427-18 | ML - Milliliter | 81033-427 | 91e5225d-fa6e-4957-baa4-8e02b112b847 | 1 | 2026-03-17 |
| 81033-427-20 | ML - Milliliter | 81033-427 | 6d36b226-34e6-4c4e-a8c2-cf3af3bbebdc | 1 | 2026-03-17 |
openFDA label cross-check#
OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.
| Brand | Generic | Manufacturer | SPL set ID | Effective date | Available safety fields | Join |
|---|---|---|---|---|---|---|
| Sterile Water | WATER | REMEDYREPACK INC. | 5dd5d148-6e23-41de-bff5-551b2aea9598 | 2026-08-24 | Warnings, Adverse reactions | 059QF0KO0R |
| Aging Eye Formula | CINERARIA MARITIMA, EYE (SUIS), CALCAREA FLUORICA, CAUSTICUM, PHOSPHORUS, SILICEA, ZINCUM METALLICUM, GERMANIUM METALLICUM, NATRUM MURIATICUM | Nutritional Specialties, Inc. | d5b44f79-5299-4b31-ba45-0e511cdbe17c | 2026-08-24 | Warnings | 451W47IQ8X |
| Bio Combination 28 | SCHUESSLER SALTS | LDD Bioscience Private Limited | 597caf33-5107-9dec-e063-6294a90a5fcd | 2026-08-20 | Warnings | 451W47IQ8X |
| Sodium Chloride | SODIUM CHLORIDE | YYBA CORP | 597f3347-647c-3545-e063-6294a90abab2 | 2026-08-20 | Warnings | 451W47IQ8X |
| Sodium Chloride | SODIUM CHLORIDE | Fresenius Kabi USA, LLC | 2e5fe9f4-78e5-4af4-8bf9-9680e5dc5e88 | 2026-08-20 | Warnings, Adverse reactions | 451W47IQ8X |
| Sinusforce-HP | ARSENICUM ALBUM, HEPAR SULPHURIS CALCAREUM, KALI BICHROMICUM, LYCOPODIUM CLAVATUM, MERCURIUS SOLUBILIS, NATRUM MURIATICUM, PHOSPHORUS, PULSATILLA (PRATENSIS), SEPIA | BioActive Nutritional, Inc. | 53c96680-210b-4426-8b41-3b9a882848dd | 2026-08-20 | Warnings | 451W47IQ8X |
| CVS Saline | NASAL | CVS PHARMACY | f02c41b0-c78e-41cd-aa4a-2756bbe92087 | 2026-08-19 | Warnings | 451W47IQ8X |
| Dextrose and Sodium Chloride | DEXTROSE MONOHYDRATE AND SODIUM CHLORIDE | Fresenius Kabi USA, LLC | df18a603-ca12-4b26-83b5-9dd07b6453ab | 2026-08-18 | Warnings, Adverse reactions | 451W47IQ8X |
| DELFLEX | DEXTROSE MONOHYDRATE, SODIUM CHLORIDE, SODIUM LACTATE, CALCIUM CHLORIDE, MAGNESIUM CHLORIDE | Fresenius Medical Care Renal Therapies Group, LLC | bbc5b820-4973-11e2-a192-0002a5d5c51b | 2026-08-18 | Warnings, Adverse reactions | 451W47IQ8X |
| DELFLEX | DEXTROSE MONOHYDRATE, SODIUM CHLORIDE, SODIUM LACTATE, CALCIUM CHLORIDE, MAGNESIUM CHLORIDE | Fresenius Medical Care Renal Therapies Group, LLC | c29bdfa0-4976-11e2-939b-0002a5d5c51b | 2026-08-18 | Warnings, Adverse reactions | 451W47IQ8X |
| DELFLEX | DEXTROSE MONOHYDRATE, SODIUM CHLORIDE, SODIUM LACTATE, CALCIUM CHLORIDE, MAGNESIUM CHLORIDE | Fresenius Medical Care Renal Therapies Group, LLC | 515dcee0-3e34-11e2-a25f-0800200c9a66 | 2026-08-18 | Warnings, Adverse reactions | 451W47IQ8X |
| Leader Dry Eye Relief Eye Drops | GLYCERIN, HYPROMELLOSE, POLYETHYLENE GLYCOL 400 | CARDINAL HEALTH 110, LLC. DBA LEADER | 2ded4bda-b3c3-4521-8701-5c8446fd148b | 2026-08-17 | Warnings | PDC6A3C0OX |
| BM BM63 DROPS | CEANOTHUS, KALI ARSEN, KALI MUR, SELENIUM, THALLIUM, WIESBADEN | BM Private Limited | 59006d82-610a-2e08-e063-6394a90af1ed | 2026-08-14 | Warnings | 059QF0KO0R |
| BM BM164 DROPS | ARUM TRYPH, CAUSTICUM, BALSAMUM PERU, HELONIAS DIO, ACID PHOS, GLYCERINUM, EQUISETUM | BM Private Limited | 5902770f-eb01-d099-e063-6394a90ad3eb | 2026-08-14 | Warnings | PDC6A3C0OX |
| BM BM173 DROPS | ECHINACEA, EUPHRASIA, NATRUM MUR, RHUS TOX, SILICEA, SULPHUR, URTICA UREN | BM Private Limited | 59036ca4-e7bb-bbe7-e063-6394a90a410a | 2026-08-14 | Warnings | 451W47IQ8X |
| Natural Lift Lack of energy - Fatigue | AVENA SATIVA 9C, GELSEMIUM SEMPERVIRENS 9C, PANAX GINSENG 3C, NATRUM MURIATICUM 9C | SEVENE USA | 551194c4-dfd8-c42d-e063-6294a90aecee | 2026-08-13 | Warnings | 451W47IQ8X |
| BM BM59 DROPS | CALC CARB, DULCAMARA, HEPAR SULPH, LYCOPODIUM, NAT MUR, SULPHUR, THUJA OCC | BM Private Limited | 58ef0755-c2cd-b7c2-e063-6294a90a2707 | 2026-08-13 | Warnings | 451W47IQ8X |
| Lacosamide | LACOSAMIDE | Novadoz Pharmaceuticals LLC | b9a0ca8c-593c-48e8-b2a7-d30d5f6e6a9b | 2026-08-12 | Warnings, Adverse reactions | 993856 563KS2PQY5 |
| Lacosamide | LACOSAMIDE | Westminster Pharmaceuticals, LLC | ecb8b33e-7cbd-4f5e-9fe9-e72dff9bcb86 | 2026-08-11 | Warnings, Adverse reactions | 563KS2PQY5 |
| Lacosamide | LACOSAMIDE | Glenmark Pharmaceuticals Limited | 458e80da-8fc1-4715-9b4b-bc4f388f933f | 2026-08-11 | Warnings, Adverse reactions | 993856 563KS2PQY5 |
Reported adverse events (FAERS/openFDA)#
Adverse event summaries are temporarily unavailable. Other product information remains available.